Spectrum: Local Antimicrobial Stewardship, for Saskatchewan Health Authority - Saskatoon Area

Escherichia coli - Antibiogram Data

Outpatients
% of Isolates Susceptible

Antibiogram
Meropenem100%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ertapenem100%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Cefoxitin98%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Nitrofurantoin98%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Piperacillin-tazobactam98%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ceftriaxone96%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ceftazidime96%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Gentamicin95%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Tobramycin95%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ciprofloxacin94%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Cefazolin85%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Amoxicillin-clavulanate84%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Trimethoprim-Sulfamethoxazole77%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Ampicillin58%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram
Amoxicillin58%
n = 754

4.1% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Note

  • January 1, 2018 - December 31, 2018

  • R: Intrinsically resistant or less than 25% empiric susceptibility